Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study | Zendy

Hideki Ueno | Zendy; Tatsuya Ioka | Zendy; Masafumi Ikeda | Zendy; Shinichi Ohkawa | Zendy; Hiroaki Yanagimoto | Zendy; Narikazu Boku | Zendy; Akira Fukutomi | Zendy; Kazuya Sugimori | Zendy; Hideo Baba | Zendy; Kenji Yamao | Zendy; T Shimamura | Zendy; Masayuki Sho | Zendy; Masayuki Kitano | Zendy; AnnLii Cheng | Zendy; Kazuhiro Mizumoto | Zendy; JenShi Chen | Zendy; Junji Furuse | Zendy; Akihiro Funakoshi | Zendy; Takashi Hatori | Zendy; Taketo Yamaguchi | Zendy; Shinichi Egawa | Zendy; Atsushi Satō | Zendy; Yasuo Ohashi | Zendy; Takuji Okusaka | Zendy; Masao Tanaka | Zendy

Open Access

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

Author(s) -

Hideki Ueno,

Tatsuya Ioka,

Masafumi Ikeda,

Shinichi Ohkawa,

Hiroaki Yanagimoto,

Narikazu Boku,

Akira Fukutomi,

Kazuya Sugimori,

Hideo Baba,

Kenji Yamao,

T Shimamura,

Masayuki Sho,

Masayuki Kitano,

AnnLii Cheng,

Kazuhiro Mizumoto,

JenShi Chen,

Junji Furuse,

Akihiro Funakoshi,

Takashi Hatori,

Taketo Yamaguchi,

Shinichi Egawa,

Atsushi Satō,

Yasuo Ohashi,

Takuji Okusaka,

Masao Tanaka

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.43.3680

Subject(s) - gemcitabine , medicine , hazard ratio , pancreatic cancer , deoxycytidine , chemotherapy , antimetabolite , gastroenterology , oncology , phases of clinical research , cancer , confidence interval

The present phase III study was designed to investigate the noninferiority of S-1 alone and superiority of gemcitabine plus S-1 compared with gemcitabine alone with respect to overall survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research